May 14, 2026 a 08:38 am
GEHC: Analysts Ratings - GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. has been attracting significant attention from analysts, particularly given its diverse segments spanning imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics. As of the latest analysis, the sentiment shows a slight favor towards buying recommendations; however, there is an observable trend of holding positions steady. Investors are encouraged to examine the detailed insights provided below to better understand the stock's potential trajectory and risk factors.
Historical Stock Grades
Reviewing the analyst ratings for GE HealthCare Technologies Inc., there is a visible trend of stability in analyst sentiment over the past months. The most recent data point is from May 2026, reflecting a consistent number of "Strong Buy" ratings at 3, with a slight decline in "Buy" recommendations to 10, compared to the previous month.
| Recommendation | Number | Score |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 10 | |
| Hold | 6 | |
| Sell | 1 | |
| Strong Sell | 0 |
Sentiment Development
- The overall number of recommendations fluctuated marginally over the last year, with noticeable stability in "Strong Buy" and "Buy" counts.
- From May 2025 to May 2026, the "Hold" ratings saw a minor increase, suggesting a cautious outlook by analysts.
- The consistency in "Strong Sell" recommendations, remaining at zero, indicates low negative sentiment from the analyst community.
Percentage Trends
- Analysis reveals that while "Buy" ratings have seen a slight decrease, "Hold" ratings have filled the gap, indicating a cautious approach.
- Overall, the percentage share of "Strong Buy" remained consistent at approximately 15% over the observed period.
- The shift from "Buy" to "Hold" suggests increased prudence among analysts, reflecting possible uncertainties or market recalibrations.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-04-30 | Neutral | Neutral | Citigroup |
| 2026-04-30 | Neutral | Buy | Goldman Sachs |
| 2026-04-30 | Equal Weight | Equal Weight | Barclays |
| 2026-04-30 | Outperform | Outperform | Evercore ISI Group |
| 2026-04-30 | Overweight | Overweight | Wells Fargo |
Analyst Recommendations with Change of Opinion
Recent months reveal several notable changes in analyst opinion:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-04-30 | Neutral | Buy | Goldman Sachs |
| 2026-01-15 | Sell | Neutral | UBS |
| 2025-10-07 | Neutral | Buy | Citigroup |
| 2025-05-05 | Neutral | Sell | UBS |
| 2025-03-11 | Buy | Neutral | Goldman Sachs |
Interpretation
From the data, it can be observed that analysts appear more cautious, with some downgrades in opinions suggesting mixed confidence in the stock's short-term performance. While no significant emergence of negative sentiment is indicated by a lack of "Strong Sell" ratings, the shift to more neutral stances might reflect market uncertainties or expectations of slower growth. Overall, the stability in recommendations signals a belief in the stock's resilience with moderate growth potential.
Conclusion
GE HealthCare Technologies Inc. presents a balanced risk-reward profile as per the latest analyst ratings. Despite some downgrades and a shift towards "Hold" and "Neutral" recommendations, the lack of significant negative sentiment underscores underlying confidence. The market seems to be factoring in some uncertainties, with cautious optimism evident. Investors should weigh this sentiment against broader market trends and company-specific developments to make informed decisions.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years